Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
The Journal of Physical Chemistry Letters
|
January 3, 2024
Best-of-Both-Worlds Predictive Approach to Dissociative Chemisorption on Metals
Andrew D Powell, Nick Gerrits, Theophile Tchakoua, et al.
Plos One
|
May 8, 2014
Reduced gamma oscillations in a mouse model of intellectual disability: a role for impaired repetitive neurotransmission?
Andrew D Powell, Pierre-Philippe Saintot, Kalbinder K Gill, et al.
Neuron
|
February 3, 2007
Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice
Giovanna R Mallucci, Melanie D White, Michael Farmer, et al.
British Journal of Pharmacology
|
September 29, 2016
Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT<sub>3</sub> A receptor
Andrew D Powell, Gillian Grafton, Alexander Roberts, et al.
Human Molecular Genetics
|
April 30, 2009
Inhibition of RhoA pathway rescues the endocytosis defects in Oligophrenin1 mouse model of mental retardation
Malik Khelfaoui, Alice Pavlowsky, Andrew D Powell, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 23, 2010
High-frequency network activity, global increase in neuronal activity, and synchrony expansion precede epileptic seizures in vitro
Premysl Jiruska, Jozsef Csicsvari, Andrew D Powell, et al.
British Journal of Pharmacology
|
April 19, 2013
5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor
Amy S Newman, Nikolaos Batis, Gillian Grafton, et al.
Nature Neuroscience
|
November 29, 2018
Loss of neuronal network resilience precedes seizures and determines the ictogenic nature of interictal synaptic perturbations
Wei-Chih Chang, Jan Kudlacek, Jaroslav Hlinka, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 28, 2020
CSTI-300 (SMP-100); a Novel 5-HT<sub>3</sub> Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
Alexander Roberts, Gillian Grafton, Andrew D Powell, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
The Journal of Physical Chemistry Letters
|
January 3, 2024
Best-of-Both-Worlds Predictive Approach to Dissociative Chemisorption on Metals
Andrew D Powell, Nick Gerrits, Theophile Tchakoua, et al.
Plos One
|
May 8, 2014
Reduced gamma oscillations in a mouse model of intellectual disability: a role for impaired repetitive neurotransmission?
Andrew D Powell, Pierre-Philippe Saintot, Kalbinder K Gill, et al.
Neuron
|
February 3, 2007
Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice
Giovanna R Mallucci, Melanie D White, Michael Farmer, et al.
British Journal of Pharmacology
|
September 29, 2016
Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT<sub>3</sub> A receptor
Andrew D Powell, Gillian Grafton, Alexander Roberts, et al.
Human Molecular Genetics
|
April 30, 2009
Inhibition of RhoA pathway rescues the endocytosis defects in Oligophrenin1 mouse model of mental retardation
Malik Khelfaoui, Alice Pavlowsky, Andrew D Powell, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 23, 2010
High-frequency network activity, global increase in neuronal activity, and synchrony expansion precede epileptic seizures in vitro
Premysl Jiruska, Jozsef Csicsvari, Andrew D Powell, et al.
British Journal of Pharmacology
|
April 19, 2013
5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor
Amy S Newman, Nikolaos Batis, Gillian Grafton, et al.
Nature Neuroscience
|
November 29, 2018
Loss of neuronal network resilience precedes seizures and determines the ictogenic nature of interictal synaptic perturbations
Wei-Chih Chang, Jan Kudlacek, Jaroslav Hlinka, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 28, 2020
CSTI-300 (SMP-100); a Novel 5-HT<sub>3</sub> Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
Alexander Roberts, Gillian Grafton, Andrew D Powell, et al.
Page
of 3